A letter to the editor is presented in response to the article "Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor," by C. Reimer and colleagues in the 2016 issue.